XTalks

NOVEMBER 23, 2023

As of February, new regulations require producers of infant formula to significantly invest in reformulating, testing, certifying and re-registering their products for the Chinese market, which may also necessitate launching new marketing campaigns. This highlighted the need for more stringent labeling laws.

Contamination 103

Contamination Regulation Bacterium Allergies 103

pharmaphorum

DECEMBER 24, 2020

About a quarter of the world’s population carry the bacterium, and have a 5% to 15% chance of developing the disease. TB – caused by Mycobacterium tuberculosis – remains a massive public health problem worldwide, affecting 10.4 million patients every year and causing over a million deaths.

Bacterium 52

Bacterium Licensing Licensing Development 52

pharmaphorum

MAY 31, 2022

billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated by Pfizer’s Prevnar franchise. GlaxoSmithKline has agreed a $3.3 GSK said it is paying $2.1 billion upfront for Cambridge, Massachusetts-based Affinivax, with another $1.2

Vaccine 52

Vaccine Vaccination Bacterium Sales 52

pharmaphorum

JULY 14, 2021

The shot also includes two “conserved” pneumococcal proteins – antigens that seem always to be present in the bacterium regardless of its serotype, so could potentially provide protection against an even broader range.

Immune Response 52

Immune Response Vaccine Vaccination Protein 52

pharmaphorum

JUNE 16, 2022

The Medicines and Healthcare products Regulatory Agency’s (MHRA) gave a conditional approval to Idefirix – an enzyme derived from the bacterium Streptococcus pyogenes that breaks down immunoglobulin G (IgG) antibodies in the body – in 2020.

Antibody 52

Antibody Bacterium Medicine Clinical Trials 52

Pfizer

JANUARY 27, 2023

Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. An estimated 1.9

Bacteria 75

Bacteria Medicine Containment Manufacturing 75

Pharma in Brief

NOVEMBER 20, 2023

These distinctions are important as they determine the regulatory burden required to market a product in Canada. The substances listed in Schedule 1 include amino acids, certain vitamins, and “[a] plant or a plant material, an alga, a bacterium, a fungus or a non-human animal material”.

Production 52

Production Cosmetics Regulation Branding 52

Roots Analysis

JANUARY 29, 2024

The treatments / products provided by medical aesthetics companies used for facial aesthetic procedures have been mentioned below: Botulinum toxin: It is a toxin produced by a bacterium, Clostridium botulinum , commonly referred to as Botox. The report answers many key questions related to this market.

Filler 40

Filler Cosmetics Botox Marketing 40

XTalks

NOVEMBER 10, 2020

Given that weeds grow fast, genetic material from the virus is incorporated into the leaves, using a de-fanged bacterium that infects plants, when the plant is five to six weeks old. This is because Medicago’s VLPs are grown in the hardy Australian weed, Nicotiana benthamiana , which is a relative of the tobacco plant.

Vaccination 52

Vaccination Vaccine Trials Immune Response 52

XTalks

AUGUST 2, 2023

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

SEPTEMBER 8, 2022

GBS is responsible for nearly half of all life-threatening infections in newborns, and around 15-25% of women carry the bacterium and risk transmitting it to their child in utero, during birth, or during their first months of life. It has previously also been given fast-track status.

Vaccine 52

Vaccine Vaccination Bacterium Licensing 52

XTalks

DECEMBER 24, 2020

But there are glimmers of hope — the COVAX advanced market commitment provides the mechanism for countries to access, at least for the first 20 percent of their population, a pretty significant supply of vaccines.”. Dr. Omer says, “it would be a tragedy if the disparities in resources translate into disparities to access to vaccines.

Life Science 111

Life Science Vaccine Vaccination Gene 111